Atrial natriuretic peptide is a potent diuretic hormone secreted by the atria in response to volume expansion. We examined the effect of resting tension on atrial natriuretic peptide secretion by rat atria superfused in vitro. Left atria were hooked between an electrode and force transducer and superfused with medium 199. The atria were studied at a pacing frequency of 0 or 3 Hz. Atrial natriuretic peptide content of the superfusate was measured by radioimmunoassay. In nonpaced and paced atria, increasing resting tension three-to five-fold caused immunoreactive atrial natriuretic peptide secretion to increase by 35 ±5% (mean ± SEM, n = 6, p<0.01) and 30 ± 3% (n = 4, p<0.01), respectively. Lowering resting tension by 50% in nonpaced and paced atria lowered immunoreactive atrial natriuretic peptide secretion by 30 ± 3% (n = 7, p<0.01) and 24 ± 3% (n = 6, p<0.01), respectively. To exclude the possibility that release of norepinephrine or acetylcholine from endogenous nerve endings was mediating this effect, the atria were superfused with the combination of propranolol 0.1 £tM, phentolamine 1.0 /xM, and atropine 10 fiM. These concentrations of the antagonists were 125-fold or higher than their K d for binding to their respective receptors. The antagonists did not block the rise in immunoreactive atrial natriuretic peptide secretion; neither did they inhibit an established rise in immunoreactive atrial natriuretic peptide secretion induced by increasing the resting tension. We conclude that changes in resting tension affect atrial natriuretic peptide secretion in atria that are either quiescent or contracting, indicating that beating is not necessary for stretchinduced atrial natriuretic peptide release from rat atria. The influence of resting tension on immunoreactive atrial natriuretic peptide secretion appears to be the result of direct mechanical stretch, not mediated by release of endogenous neurotransmitters. Thus, enhanced atrial natriuretic peptide secretion by volume expansion may be mediated in vivo, at least in part, by mechanical distent ion of the atrium. (Circulation Research 1986;59:105-109) KEY WORDS • Atrial natriuretic peptide * resting tension • atrium • rat * stretch From the University of Oklahoma Health Sciences Center and the Veterans' Administration Medical Center (R.J.S.) and the Oklahoma Medical Research Foundation (J.L.), Oklahoma City, Oklahoma.
A TRIAL natriuretic peptide (ANP) is a newly dis-/\ covered hormone secreted by the atria of the X \. heart. 12 ANP has potent natriuretic and diuretic properties. 3 ' 4 Its physiological role is believed to be that of protecting the organism against volume overload as suggested by a rise in plasma ANP with acute or chronic volume expansion. 2 ' 6-'° Enhanced ANP secretion during volume expansion is associated with an increase in right atrial pressure, suggesting that atrial wall tension per se may play a significant role in mediating this response. 2 -6 -9 In this study, we examine the effect of changing resting atrial wall tension on ANP secretion in paced and nonpaced rat atria superfused in vitro.
Materials and Methods
Female Sprague-Dawley rats weighing 200-225 g were killed by decapitation. Hearts were quickly removed and allowed to beat for 1-2 minutes in medium 199" with Earle's modified salts (KC14.0 mM) gassed with 95% O 2 /5% CO 2 to remove blood. Left atria were immediately removed and hooked between a platinum electrode and force transducer (Grass, model FT03C). Each force transducer was attached to a dovetail slide by which adjustments in resting tension were made. Resting tension was adjusted to 1 g initially and at 30 minutes. Each atrium was lowered into a 2.5-ml reservoir chamber. Medium 199, gassed with 95% O 2 /5% CO 2 , was pumped in and out of the six reservoir chambers by a 12-channel peristaltic pump at a flow rate of 1.2 ml/min. The reservoir chambers were 5-ml syringes with the inflow at the tip, and outflow achieved by a tube inserted into the side of the syringe. The medium 199 within the reservoir chambers was gassed with 95% O 2 /5% CO 2 through a small Teflon tube. The exiting superfusate was collected in fractions at 2-minute intervals on ice. Recovery of 125 I-ANP, which was run through the system, was 101 ± 1% (n = 8). The reservoir chambers were maintained at 37°C by waterjacketed cylindrical holders. Atria were either unpaced or paced with monophasic 10-msec pulses through point electrodes at twice the threshold voltage for contraction. Unpaced atria were quiescent except for occasional spontaneous contractions such as those apparent in the second tracing of Figure 1 . Resting tension and atrial contractions were recorded on a six-channel retilinear oscillographic recorder. The atria were allowed to stabilize for 70 minutes before beginning each experiment.
ANP antibody was purchased from Peninsula Laboratories (lot 006107-2). This antibody binds to the Cterminal end of the peptide. Cross-reactivity is 100% with human aANP, rat aANP, and atriopeptin III. Synthetic human aANP was labelled with [ 125 I]iodide by the chloramine T method. 12125 I-ANP was separated from free iodide by use of a Sep-Pak. I25 I-ANP was purified by reverse phase high pressure liquid chroma-tography using a Bondapak C 18 column and a linear gradient from acetonitrile: water (1:5) to 100% acetonitrile. I25 I-ANP eluted at 46% acetonitrile. The specific activity of the I25 I-ANP was 380 /u.Ci//ug. 13 The radioimmunoassay buffer consisted of 100 mM sodium phosphate (pH 7.4), 50 mM NaCl, 0.1% BSA, 0.1% Triton X-100, and 0.01% NaN 3 . I25 I-ANP, 5000 dpm, was incubated with the antibody (final dilution 1/60,000) in a total volume of 0.3 ml. This allowed a maximum of 0.2 ml of sample to be assayed. The assay incubation period was 48 hours at 4°C. Bound and free peptide were separated by the double antibody precipitation technique. The bound fraction was counted. The standard curve consisted of 7 points from 5 to 200 pg of rat aANP. The standard curve and unknowns were evaluated by the "RIA PROG-1980" computer program of Rodbard and Lewald, 14 which performs a logit-log transformation of the standard curve. The slope was -1.07 ± 0.02 (mean ± SEM, n = 10) and ED 50 was 24 ± 3 pg. The sensitivity was 3 pg/tube. The blank of the assay was 1 pg/tube as determined by adding 200 (xl of medium 199. The intra-and interassay coefficients of variation were 8 and 13%, respectively. Nonspecific binding was 4%. The assay was validated in the following manner. Rat aANP was added to medium 199 to give a concentration of 1 pg//xl. Aliquots of 20, 40, and 150 /x\ read 24 ± 1, r- 43 ± 2, and 150 ± 5 pg (n = 4), respectively. Serial dilutions (n = 5) of a superfusate sample gave a slope of -1.17 ± 0.04 (mean ± SD) which was not significantly different (p = 0.69) from the slope of the standard curve, -1.23 ± 0.06. Mean baseline ANP measurements and mean plateau ANP measurements achieved after adjustments in resting tension were used for data analysis. Mean baseline values were determined from 4 to 7 timed samples collected just prior to a change in resting tension. Mean plateau values were determined from 4 to 9 timed samples obtained after a change in resting tension and when ANP secretion had stabilized, which averaged 8 minutes after a change in resting tension. The coefficient of variation of the mean was <10%. Comparisons were made by paired Mest, using the mean of the ANP measurements. Comparisons between paced and nonpaced atrial preparations were made by unpaired Mest.
Radioligand-binding assays were conducted with rat atria homogenized in 10mMTris-HCl(pH7.4), 1 mM EDTA, and 10% sucrose at 4°C. After filtration through four layers of gauze, the homogenate was centrifuged at 30,000g for 15 minutes. The pellet was resuspended in the same buffer. Membranes and radioligand were incubated in 100-/xl volume at 21°C for 1 hour before being filtered over GF/C glass fiber filters (Brandel). Table 1 .
Results
The upper two tracings in Figure 1 illustrate the effect that changing resting tension has on immunoreactive ANP (ANP-IR) secretion in two separate atrial preparations which were not paced. Increasing resting tension from 0.4 to 1.5 g increased ANP-IR secretion, and decreasing resting tension from 0.8 to 0.4 g decreased ANP-IR secretion. The lower two tracings in Figure 1 illustrate the effect that changing resting tension has an ANP-IR secretion in two separate atrial preparations which were electrically paced at 3 Hz. As with the nonpaced atria, increasing resting tension from 0.5 to 1.5 g increased ANP-IR secretion, and decreasing resting tension from 0.5 to 0.3 g decreased ANP-IR secretion. The results of a series of experiments are presented in Figure 2 . ANP-IR secretion rose 35 ± 5 and 30 ± 3% (mean ± SEM) above baseline (p<0.01 for each), with a net increase in resting tension of 1.2 ± 0.1 and 1.1 ± 0.1 g in nonpaced and paced atria, respectively. ANP-IR secretion fell 30 ± 3 and 24 ± 3% from baseline (p <0.01 for each) with a net decrease in resting tension of 0.3 ±0.1 and 0.4 ± 0.1 g in nonpaced and paced atria, respectively. The increases in resting tension reflected a three-to five-fold rise above baseline, and the decreases in resting tension reflected a 50% fall. The differences in the percent changes in ANP-IR secretion for nonpaced and paced atria were not significantly different for increases in resting tension (p = 0.37) or decreases in resting tension (p = 0.18). In paced and nonpaced control atria, where resting tension was not changed, ANP-IR secretion remained stable for the duration of the experiment. To examine the possibility that a variable release of norepinephrine or acetylcholine from endogenous nerve endings was mediating the secretory changes in ANP-IR, we superfused atria paced at 3 Hz with the combination of 0.1 /i,M propranolol, 1.0 fxM phentolamine, and 10 fiM atropine, known blockers of /3-adrenergic, a-adrenergic, and cholinergic muscarinic receptors, respectively. These concentrations of antagonist were 125-fold or higher than the K d for antagonist binding to receptors, as illustrated in Table  1 . Supervision with these antagonists did not block the rise in ANP-IR secretion ( Figure 3A ) neither did they 3.2 *Radioligand equilibrium-binding studies were conducted using six concentrations of each radioligand. Receptor densities and radioligand dissociation constants (K d ) were estimated by the method of Scatchard. ' 5 Binding parameters derived from Scatchard plots were used as starting estimates for nonlinear least-squares fits of binding data to an untransformed single site binding model which was solved by interpolation using the method of Marquadt as modified by Tabata and Ito. 17 Nonspecific binding to /3-adrenergic, cholinergic muscarinic, and a r adrenergic receptors was determined in the presence of propranolol 0. Antagonist dissociation constants were calculated from IC50 values for inhibition of radioligand binding with correction for the concentration of radioligands and the concentration of receptors as described by Linden. 18 inhibit an established rise in ANP-IR secretion subsequent to increasing resting tension ( Figure 3B ).
Discussion
The results of this study suggest that mechanical stretching of atria directly influences the rate of ANP secretion. Higher centers of neural input are excluded as the sole mediator of the ANP secretory response to changes in atrial wall tension by this in vitro study. However, this study does not exclude a role for higher neural centers in influencing the ANP secretory response to changes in blood volume in vivo. Theoretically, local release of acetylcholine or norepinephrine could influence ANP secretion, since epinephrine (through an a-adrenergic receptor mechanism) and acetylcholine have been reported to stimulate bioactive natriuretic activity in statically incubated atria. 1930 In this study, it is doubtful that the release of endogenous neurotransmitters is responsible for stretch-related changes in ANP secretion since superfusion with the combination of propranolol, phentolamine, and atropine at concentrations over 125 times higher than their K d for receptor binding failed to inhibit the rise in ANP secretion induced by increasing resting tension. Although a massive release of neurotransmitters could, in principle, overcome these antagonists, such release would markedly influence contractility, and no such effect was observed.
Atrial beating does not appear to play an important role in mediating the effect of tension on ANP secretion, since changes in resting tension influence ANP secretion in nonpaced as well as electrically paced atria. However, we have found that changes in the frequency of atrial contraction can also influence ANP secretion (unpublished observation). The mechanism responsible for mediating the changes in ANP secretion in response to changes in atrial wall tension remains to be elucidated.
The observations from this study are consistent with those previously reported. Increases in right or left atrial pressure in vivo are associated with a rise in plasma ANP or natriuretic hormone activity measured by bioassay. 2 -6 -9 In a single in vitro whole isolated heart study, an increase in right atrial pressure was associated with a rise in ANP secretion. 2 However, the frequency of beating was not controlled in this study. The present study provides proof that the level of atrial wall tension directly affects ANP secretion using a sensitive superfusion technique.
